| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/21/2012 | US8120791 Image synthesizing apparatus |
| 02/21/2012 | US8119789 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 02/21/2012 | US8119786 Nucleic acids encoding CCL27 |
| 02/21/2012 | US8119783 FGF variants and methods for use thereof |
| 02/21/2012 | US8119776 Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency |
| 02/21/2012 | US8119769 Complement depletion using recombinant human C-3 derivatives |
| 02/21/2012 | US8119768 Compositions and methods for modulating AMPA receptor-mediated excitotoxicity |
| 02/21/2012 | US8119767 Post-translational modifications and clostridial neurotoxins |
| 02/21/2012 | US8119631 Inhibitors of interleukin-1β converting enzyme |
| 02/21/2012 | US8119609 Apoptosis and increased production of ceramides and DAG are normalized in the presence of antioxidants |
| 02/21/2012 | US8119608 Specific inhibition of expression of target gene in mammals using short double stranded RNA; dsRNA less than 49 nucleotides in length, has nucleotide sequence complementary to part of target gene; treating cancer, Alzheimer's disease |
| 02/21/2012 | US8119606 Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan |
| 02/21/2012 | US8119605 Soluble tumor necrosis factor receptor treatment of medical disorders |
| 02/21/2012 | US8119604 Polypeptide formulation |
| 02/21/2012 | US8119603 Modified human interferon polypeptides and their uses |
| 02/21/2012 | US8119602 Administration of HCV protease inhibitors in combination with food to improve bioavailability |
| 02/21/2012 | US8119601 Mitochondria protein; anticancer agents; antiproliferative agents; viricides |
| 02/21/2012 | US8119600 Lysozyme from human recombinant, non-human, hen egg white; chitosan, pullulan polysaccharide; peroxidase, papain, serine protease, lactic acid, vitamins, minerals as active agents; lozenge, tablet, pill, capsule, chewing-gum, effervescent tablet and sachet, cream, lotion, powder, gel, mask, sprayable |
| 02/21/2012 | US8119599 Enhancing non-denatured collagenous tissues to increase resistance to tearing, fissuring, rupturing, and/or delamination via genipin crosslinking treatment |
| 02/21/2012 | US8119598 Synthetic peptide materials for joint reconstruction, repair and cushioning |
| 02/21/2012 | US8119597 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 02/21/2012 | US8119596 Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy and anti-cancer activity and methods of use |
| 02/21/2012 | US8119595 Stable, aqueous solution of human erythropoietin, not containing serum albumin |
| 02/21/2012 | US8119594 Method of modulating integrin mediated cellular activity and agents useful for same |
| 02/21/2012 | US8119593 Method of treating diabetes type 2 by metformin and an ultrarapid acting insulin |
| 02/21/2012 | US8119592 Compounds and methods for inhibiting hepatitis C viral replication |
| 02/21/2012 | US8119591 Methods and compositions for regenerating articular cartilage |
| 02/21/2012 | US8119590 Apolipoprotein A-I (ApoA-I), preferably a variant form such as Apolipoprotein A-I Milano (ApoA-IM), alone or more preferably in combination with a lipid carrier such as phospholipids or other drug, can be administered locally |
| 02/21/2012 | US8119405 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 02/21/2012 | US8119397 Therapeutic agents and therapeutic methods for treating injured tissue |
| 02/21/2012 | US8119395 Vaccines, immunotherapeutics and methods for using the same |
| 02/21/2012 | US8119392 Tissue engineering; modifying cell surface using micropatterning; amplified polymer containing pyrrolidone units and (meth)acrylate units |
| 02/21/2012 | US8119386 Proteases and variants thereof |
| 02/21/2012 | US8119370 Activatable recombinant neurotoxins |
| 02/21/2012 | US8119340 Methods and compositions for diagnosis and treatment of B cell chronic lymphocytic leukemia |
| 02/21/2012 | US8119161 Blister pack and solid dosage form therefor |
| 02/21/2012 | US8119157 Pharmaceutical compositions for lipophilic drugs |
| 02/21/2012 | US8119147 Compositions produced using enteric pathogens and methods of use |
| 02/21/2012 | US8119144 nucleotide sequences encoding HIV-1 Clade A Gag, Pol (RT and Int), and Nef ("GRIN), HIV-1 Clade A Gag, RT and Nef ("GRN") or HIV-1 Clade A Env; generating an immune response against HIV-1 |
| 02/21/2012 | US8119136 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 02/21/2012 | US8119127 Cytokine antagonists for neurological and neuropsychiatric disorders |
| 02/21/2012 | US8119126 anti-solid cancer agent; CXCR4 (chemokine) inhibitor; tissue-repairing agent comprising a CXCR4 potentiator |
| 02/21/2012 | US8119125 Compositions and methods for enhanced gastrointestinal stability of oligopeptides and polypeptides |
| 02/21/2012 | US8119124 Debriding composition from bromelain and methods of production thereof |
| 02/21/2012 | US8119123 Compositions comprising vascular and myocyte progenitor cells and methods of their use |
| 02/21/2012 | US8119121 Delivering a concentrated amount of stem cells obtained from adipose tissue to a patient |
| 02/21/2012 | US8119116 Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production |
| 02/21/2012 | US8119114 Polymer conjugates of mutated neublastin |
| 02/21/2012 | CA2675025C Inhibitor of herpesvirus infection, method for inhibition of herpesvirus infection, and use thereof |
| 02/21/2012 | CA2657911C Pharmaceutical compositions for sustained release delivery of peptides |
| 02/21/2012 | CA2568995C Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 02/21/2012 | CA2527125C Methods for preventing hyperthyroidism in a cat and composition comprising limited iodine |
| 02/21/2012 | CA2487362C Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes |
| 02/21/2012 | CA2483908C Vascularization enhanced graft constructs |
| 02/21/2012 | CA2468933C Method for obtaining oestrogen from mare's urine |
| 02/21/2012 | CA2439123C Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 02/21/2012 | CA2433244C Injectable microdispersions for medical applications |
| 02/21/2012 | CA2427080C Platelet aggregation inhibitor and supplement food effective for inhibiting platelet aggregation |
| 02/21/2012 | CA2418962C Anti-dual integrin antibodies, compositions, methods and uses |
| 02/21/2012 | CA2412460C Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 02/21/2012 | CA2407680C Dendritic cell co-stimulator molecules |
| 02/21/2012 | CA2373300C Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 02/21/2012 | CA2354045C New cancer treatments |
| 02/21/2012 | CA2350185C Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 02/21/2012 | CA2349760C Bovine cells expressing adeno virus essential functions for propagation of recombinant adenoviral vectors |
| 02/21/2012 | CA2322055C Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 02/21/2012 | CA2321934C Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms |
| 02/21/2012 | CA2302866C Genetically modified tumor-targeted bacteria with reduced virulence |
| 02/21/2012 | CA2297303C Novel peptides and polypeptides useful for regenerating the nervous system |
| 02/21/2012 | CA2296841C Tropoelastin derivatives |
| 02/21/2012 | CA2269085C Rainbow trout il1.beta.; encoding nucleic acid; materials and methods |
| 02/21/2012 | CA2264592C Bioconjugates and delivery of bioactive agents |
| 02/21/2012 | CA2263835C Stimulus-inducible i (kappa)b kinase [ikk] signalsome |
| 02/21/2012 | CA2158936C Compositions and methods for utilizing conditionally lethal genes |
| 02/17/2012 | CA2750329A1 Downregulation of spy1 by p53 as an essential component of p53-mediated effects |
| 02/16/2012 | WO2012021875A1 Peptidomimetic macrocycles with triazole linkers |
| 02/16/2012 | WO2012021874A1 Peptidomimetic macrocycles with thioether linkers |
| 02/16/2012 | WO2012021854A2 Treatment of penetrative injury to the brain |
| 02/16/2012 | WO2012021845A2 Improved hematopoietic stem and progenitor cell therapy |
| 02/16/2012 | WO2012021840A2 Materials and methods for designing autologous idiotype vaccines and treatment of b-cell malignancies |
| 02/16/2012 | WO2012021715A2 Stable formulations of linaclotide |
| 02/16/2012 | WO2012021698A2 Treatment of diabetes with pancreatic endocrine precursor cells |
| 02/16/2012 | WO2012021609A2 Neoadjuvant treatment of cancer with proleukin |
| 02/16/2012 | WO2012021578A1 Use of angiotensin- ii (1-7) in cell trans planation and as an agent for preventing/treating norovirus infection |
| 02/16/2012 | WO2012021512A2 Erythrocyte-binding therapeutics |
| 02/16/2012 | WO2012021249A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases |
| 02/16/2012 | WO2012021247A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
| 02/16/2012 | WO2012021141A1 Antisense antiviral compounds and methods for treating a filovirus infection |
| 02/16/2012 | WO2012021088A1 A novel conjugate of granulocyte colony-stimulating factor (g-csf) with polyethylene glycol |
| 02/16/2012 | WO2012020790A1 Anti-infective agent |
| 02/16/2012 | WO2012020364A1 Di peptide derivative for the treatment of cancer |
| 02/16/2012 | WO2012020219A2 Formulations for infusion of type b lantibiotics |
| 02/16/2012 | WO2012020218A1 Compositions and methods for inducing platelet aggregation |
| 02/16/2012 | WO2012019991A1 Methods and pharmaceutical compositions for the treatment of hiv-1 infections |
| 02/16/2012 | WO2012019533A1 Electronic cigarette's atomization composition with calcium pectate gel and preparation process and use thereof |
| 02/16/2012 | WO2012019432A1 Use of reg4 and pharmaceutical composition thereof |
| 02/16/2012 | WO2012019423A1 Angiogenesis inhibitor, method for purifying thereof and pharmaceutical composition comprising thereof |
| 02/16/2012 | WO2012019299A1 Hepatitis c inhibitor compounds |
| 02/16/2012 | WO2012019237A1 Therapeutic method for treating congestive heart failure |
| 02/16/2012 | WO2011160630A3 Glucagon analogues |